Adagio Therapeutics
1 Follower
About
Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses.
- Website
- Headquarters
- Social
Org chart
View all (14)
Tillman Gerngross
Co-Founder & CEO
Becky Dabora
Chief Technology & Manufacturing Officer
Ed Campanaro
SVP, Clinical Operations
Ellie Hershberger
Chief Development Officer
Eric Kimble
Chief Commercial Officer
Halley Gilbert
Chief Operating Officer & Chief Business Officer
Laura Walker
Co-Founder & Chief Scientific Officer
Lynn Connolly
Chief Medical Officer
Ajay Royan
Director
Howard Mayer
Director
Marc Elia
Director
Phil Chase
Director
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.